Solara Active Pharma Sciences Limited (SOLARA) - Total Liabilities

Latest as of September 2025: Rs10.36 Billion INR ≈ $112.04 Million USD

Based on the latest financial reports, Solara Active Pharma Sciences Limited (SOLARA) has total liabilities worth Rs10.36 Billion INR (≈ $112.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Solara Active Pharma Sciences Limited (SOLARA) long-term investment share to see how much of total assets are deployed in long-term investments.

Solara Active Pharma Sciences Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Solara Active Pharma Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Solara Active Pharma Sciences Limited total assets.

Solara Active Pharma Sciences Limited Competitors by Total Liabilities

The table below lists competitors of Solara Active Pharma Sciences Limited ranked by their total liabilities.

Company Country Total Liabilities
Text S.A.
WAR:TXT
Poland zł96.26 Million
Caregen Co.Ltd
KQ:214370
Korea ₩17.10 Billion
Jiangsu Jingxue Insulation
SHE:301010
China CN¥558.96 Million
Sinopower Semiconductor
TWO:6435
Taiwan NT$965.21 Million
Titan Acquisition Corp
NASDAQ:TACH
USA $13.17 Million
Laser Tek Taiwan Co Ltd
TWO:6207
Taiwan NT$2.17 Billion
AVCON Information Tech
SHE:300074
China CN¥482.85 Million
Hylink Digital Solution Co Ltd
SHG:603825
China CN¥2.37 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Solara Active Pharma Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Solara Active Pharma Sciences Limited (SOLARA) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.92 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.00 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.83 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Solara Active Pharma Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Solara Active Pharma Sciences Limited (2017–2025)

The table below shows the annual total liabilities of Solara Active Pharma Sciences Limited from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 Rs11.35 Billion
≈ $122.74 Million
-19.76%
2024-03-31 Rs14.14 Billion
≈ $152.96 Million
+1.27%
2023-03-31 Rs13.97 Billion
≈ $151.04 Million
-1.49%
2022-03-31 Rs14.18 Billion
≈ $153.33 Million
+38.89%
2021-03-31 Rs10.21 Billion
≈ $110.40 Million
-3.99%
2020-03-31 Rs10.63 Billion
≈ $114.99 Million
+6.35%
2019-03-31 Rs10.00 Billion
≈ $108.12 Million
-5.06%
2018-03-31 Rs10.53 Billion
≈ $113.89 Million
+31911263.64%
2017-03-31 Rs33.00K
≈ $356.88
--

About Solara Active Pharma Sciences Limited

NSE:SOLARA India Drug Manufacturers - Specialty & Generic
Market Cap
$290.27 Million
Rs26.84 Billion INR
Market Cap Rank
#15089 Global
#759 in India
Share Price
Rs742.05
Change (1 day)
+0.05%
52-Week Range
Rs425.55 - Rs749.15
All Time High
Rs1807.78
About

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arr… Read more